[CLDX] QoQ Quarter Result on 31-Dec-2023 [#Q4]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
26-Feb-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- -13.19%
YoY- -82.80%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Revenue 3,191 2,498 156 4,131 1,517 268 967 121.16%
PBT -42,121 -35,842 -32,808 -43,306 -38,260 -30,502 -29,361 27.11%
Tax 0 0 732 13,384 -2,979 -3,459 -6,946 -
NP -42,121 -35,842 -32,808 -43,306 -38,260 -30,502 -22,415 52.10%
Tax Rate - - - - - - - -
Total Cost 45,312 38,340 32,964 47,437 39,777 30,770 23,382 55.24%
Ratio Analysis
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
NP Margin -1,319.99 -1,434.83 -21,030.77 -1,048.32 -2,522.08 -11,381.34 -2,317.99 -31.22%
Per Share
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
EPS -0.64 -0.54 -0.56 -0.83 -0.81 -0.65 -0.47 22.78%
EPS Diluted -0.64 -0.54 -0.56 -0.83 -0.81 -0.65 -0.47 22.78%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.